Clinical Trial Update: Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating Xaluritamig in adults, adolescents, and children with relapsed or refractory Ewing sarcoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• Xaluritamig (Xaluritamig)

Snippet

Sponsor: Amgen | Conditions: Ewing Sarcoma | Phase 1 | Status: RECRUITING